Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


17.07.2017

1 Acta Cytol
1 Adv Clin Exp Med
1 AIDS
1 Ann Fam Med
1 Ann Intern Med
1 Br J Cancer
1 Brachytherapy
1 Cancer Epidemiol
1 Cancer Med
1 Cell Signal
1 Eur J Cancer Prev
1 FEBS J
1 Gene
2 Gynecol Oncol
2 Gynecol Oncol Rep
1 Int J Biol Markers
10 Int J Gynaecol Obstet
6 Int J Gynecol Cancer
2 Int J Radiat Oncol Biol Phys
1 J Epidemiol
1 J Gynecol Oncol
1 J Immunol Methods
1 J Infect Public Health
1 J Korean Med Sci
1 J Med Virol
1 J Minim Invasive Gynecol
1 J Obstet Gynaecol Res
1 J Racial Ethn Health Disparities
1 Jpn J Nurs Sci
1 Menopause
3 Oncol Lett
1 Oncol Rep
1 Oncotarget
1 Pak J Pharm Sci
1 PLoS One
1 Sci Rep
1 Tidsskr Nor Laegeforen
2 Tumour Biol
1 Yonago Acta Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. SCHNEIDER V
    Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
    Acta Cytol. 2017;61.
    PubMed     Text format     Abstract available


    Adv Clin Exp Med

  2. IZMAJLOWICZ B, Rusiecka M, Sztuder A, Stepien M, et al
    Tolerance of combined radiochemotherapy in cervical cancer patients.
    Adv Clin Exp Med. 2017 Jun 27. doi: 10.17219/acem/62454.
    PubMed     Text format     Abstract available


    AIDS

  3. VAN ZUMMEREN M, Kremer WW, Van Aardt MC, Breytenbach E, et al
    Selection of women at risk for cervical cancer in an HIV-infected SOUTH AFRICAN population.
    AIDS. 2017 Jul 7. doi: 10.1097/QAD.0000000000001583.
    PubMed     Text format     Abstract available


    Ann Fam Med

  4. NAIMER MS, Kwong JC, Bhatia D, Moineddin R, et al
    The Effect of Changes in Cervical Cancer Screening Guidelines on Chlamydia Testing.
    Ann Fam Med. 2017;15:329-334.
    PubMed     Text format     Abstract available


    Ann Intern Med

  5. PAREKH NK, Donohue JM, Men A, Corbelli J, et al
    Rethinking How to Measure the Appropriateness of Cervical Cancer Screening.
    Ann Intern Med. 2017 Jul 11. doi: 10.7326/L17-0140.
    PubMed     Text format    


    Br J Cancer

  6. LAJER CB, Garnaes E, Friis-Hansen L, Norrild B, et al
    The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
    Br J Cancer. 2017 Jul 13. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Brachytherapy

  7. NESSELER JP, Charra-Brunaud C, Salleron J, Py JF, et al
    Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Brachytherapy. 2017 Jul 7. pii: S1538-4721(17)30368.
    PubMed     Text format     Abstract available


    Cancer Epidemiol

  8. ADSUL P, Manjunath N, Srinivas V, Arun A, et al
    Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review.
    Cancer Epidemiol. 2017;49:161-174.
    PubMed     Text format     Abstract available


    Cancer Med

  9. CAMPOS NG, Tsu V, Jeronimo J, Mvundura M, et al
    Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings.
    Cancer Med. 2017 Jul 14. doi: 10.1002/cam4.1123.
    PubMed     Text format     Abstract available


    Cell Signal

  10. RAJI GR, Sruthi TV, Edatt L, Haritha K, et al
    Horizontal transfer of miR-106a/b from cisplatin resistant hepatocarcinoma cells can alter the sensitivity of cervical cancer cells to cisplatin.
    Cell Signal. 2017 Jul 11. pii: S0898-6568(17)30183.
    PubMed     Text format     Abstract available


    Eur J Cancer Prev

  11. BUDUKH A, Palayekar V, Maheshwari A, Deodhar K, et al
    Menstrual pad, a cervical cancer screening tool, a population-based study in rural India.
    Eur J Cancer Prev. 2017 Jul 12. doi: 10.1097/CEJ.0000000000000387.
    PubMed     Text format     Abstract available


    FEBS J

  12. WU L, Han L, Zhou C, Wei W, et al
    TGF-beta1-induced CK17 enhances cancer stem cell-like properties rather than EMT in promoting cervical cancer metastasis via the ERK1/2-MZF1 signaling pathway.
    FEBS J. 2017 Jul 13. doi: 10.1111/febs.14162.
    PubMed     Text format     Abstract available


    Gene

  13. LAZNIAK S, Roszak A, Balcerek A, Warenczak-Florczk Z, et al
    Role of rs13117307 single nuclear polymorphism in the risk of uterine cervical cancer from Polish population and its impact on exocyst complex component 1 expression.
    Gene. 2017 Jul 7. pii: S0378-1119(17)30523-1. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  14. DE AZEVEDO CRAS, Thuler LCS, de Mello MJG, de Oliveira Lima JT, et al
    Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer.
    Gynecol Oncol. 2017 Jul 11. pii: S0090-8258(17)31023.
    PubMed     Text format     Abstract available

  15. HARPER DM, DeMars LR
    HPV vaccines - A review of the first decade.
    Gynecol Oncol. 2017 Apr 22. pii: S0090-8258(17)30774.
    PubMed     Text format     Abstract available


    Gynecol Oncol Rep

  16. APAS PEREZ DE NUCCI A, Minig L, Perrotta M
    Patterns of cervical cancer care in Argentina: Applying ASCO recommendations adjusted by local resources.
    Gynecol Oncol Rep. 2017;21:61-66.
    PubMed     Text format     Abstract available

  17. MANGLA A, Agarwal N, Saei Hamedani F, Liu J, et al
    Metastasis of cervical cancer to breast: A case report and review of literature.
    Gynecol Oncol Rep. 2017;21:48-52.
    PubMed     Text format     Abstract available


    Int J Biol Markers

  18. SOARES S, Nogueira A, Coelho A, Assis J, et al
    Relationship between clinical toxicities and ERCC1 rs3212986 and XRCC3 rs861539 polymorphisms in cervical cancer patients.
    Int J Biol Markers. 2017 Jul 8:0. doi: 10.5301/ijbm.5000279.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  19. CAMPOS NG, Sharma M, Clark A, Lee K, et al
    The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:47-56.
    PubMed     Text format     Abstract available

  20. BASU P, Meheus F, Chami Y, Hariprasad R, et al
    Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:26-32.
    PubMed     Text format     Abstract available

  21. TSU VD
    Cervical cancer prevention for all women: Why now?
    Int J Gynaecol Obstet. 2017;138 Suppl 1:1-3.
    PubMed     Text format    

  22. OGILVIE G, Nakisige C, Huh WK, Mehrotra R, et al
    Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:15-19.
    PubMed     Text format     Abstract available

  23. ARANDA S, Berkley S, Cowal S, Dybul M, et al
    Ending cervical cancer: A call to action.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:4-6.
    PubMed     Text format     Abstract available

  24. TSU VD, Ginsburg O
    The investment case for cervical cancer elimination.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:69-73.
    PubMed     Text format     Abstract available

  25. WITTET S, Aylward J, Cowal S, Drope J, et al
    Advocacy, communication, and partnerships: Mobilizing for effective, widespread cervical cancer prevention.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:57-62.
    PubMed     Text format     Abstract available

  26. HOLME F, Kapambwe S, Nessa A, Basu P, et al
    Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:63-68.
    PubMed     Text format     Abstract available

  27. DRUMMOND JL, Were MC, Arrossi S, Wools-Kaloustian K, et al
    Cervical cancer data and data systems in limited-resource settings: Challenges and opportunities.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:33-40.
    PubMed     Text format     Abstract available

  28. WHITE HL, Meglioli A, Chowdhury R, Nuccio O, et al
    Integrating cervical cancer screening and preventive treatment with family planning and HIV-related services.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:41-46.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  29. LUCIDI A, Windemut S, Petrillo M, Dessole M, et al
    Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001045.
    PubMed     Text format     Abstract available

  30. CHANTALAT E, Vidal F, Motton S
    Letter to the Editor on "Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer": What is the Best Approach? Int J Gynecol Cancer. 2017 Mar; 27(3): 543549.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001085.
    PubMed     Text format    

  31. MACHIDA H, Eckhardt SE, Antonio C, Blake EA, et al
    Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United States.
    Int J Gynecol Cancer. 2017 Jul 12. doi: 10.1097/IGC.0000000000001068.
    PubMed     Text format     Abstract available

  32. VAN GENT MDJM, Rademaker M, van der Veer JCB, van Poelgeest MIE, et al
    Long-Term Oncological Outcome After Conventional Radical Hysterectomy Versus 2 Nerve-Sparing Modalities for Early Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jul 12. doi: 10.1097/IGC.0000000000001067.
    PubMed     Text format     Abstract available

  33. PANG T, Li M, Zhang Y, Yong W, et al
    Y Box-Binding Protein 1 Promotes Epithelial-Mesenchymal Transition, Invasion, and Metastasis of Cervical Cancer via Enhancing the Expressions of Snail.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001066.
    PubMed     Text format     Abstract available

  34. NARTEY Y, Hill PC, Amo-Antwi K, Nyarko KM, et al
    Factors Contributing to the Low Survival Among Women With a Diagnosis of Invasive Cervical Cancer in Ghana.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001088.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  35. BINGHAM B, Orton A, Boothe D, Stoddard G, et al
    Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
    Int J Radiat Oncol Biol Phys. 2017;97:1040-1050.
    PubMed     Text format     Abstract available

  36. LI N, Carmona R, Sirak I, Kasaova L, et al
    Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:164-172.
    PubMed     Text format     Abstract available


    J Epidemiol

  37. KWEON SS, Kim MG, Kang MR, Shin MH, et al
    Difference of stage at cancer diagnosis by socioeconomic status for four target cancers of the National Cancer Screening Program in Korea: Results from the Gwangju and Jeonnam cancer registries.
    J Epidemiol. 2017;27:299-304.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  38. LEE M, Choi CH, Chun YK, Kim YH, et al
    Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy.
    J Gynecol Oncol. 2017;28:e5.
    PubMed     Text format     Abstract available


    J Immunol Methods

  39. DIXON EP, King LM, Nelson R, Simkins SG, et al
    Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.
    J Immunol Methods. 2017;442:35-41.
    PubMed     Text format     Abstract available


    J Infect Public Health

  40. YUANYUE L, Baloch Z, Yasmeen N, Tao Y, et al
    The distribution of human papillomavirus genotypes in cervical cancer and intraepithelial neoplasia lesions among Chinese women in Yunnan Province.
    J Infect Public Health. 2017 Jul 8. pii: S1876-0341(17)30173.
    PubMed     Text format     Abstract available


    J Korean Med Sci

  41. LEE KN, Chang KH, Cho SS, Park SH, et al
    Attitudes Regarding HPV Vaccinations of Children among Mothers with Adolescent Daughters in Korea.
    J Korean Med Sci. 2017;32:130-134.
    PubMed     Text format     Abstract available


    J Med Virol

  42. ZHANG Q, Zhao M, Cao D, Wei X, et al
    Assessment of the Effectiveness of HPV16/18 Infection Referred for Colposcopy in Cervical Cancer Screening in Northwest of China.
    J Med Virol. 2017 Jul 15. doi: 10.1002/jmv.24902.
    PubMed     Text format     Abstract available


    J Minim Invasive Gynecol

  43. PEKER N, Gundogan S, Sendag F
    Laparoscopic Management of Huge Cervical Myoma.
    J Minim Invasive Gynecol. 2017;24:345-346.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Res

  44. LIN Y, Zhou J, Dai L, Cheng Y, et al
    Vaginectomy and vaginoplasty for isolated vaginal recurrence 8 years after cervical cancer radical hysterectomy: A case report and literature review.
    J Obstet Gynaecol Res. 2017 Jul 10. doi: 10.1111/jog.13375.
    PubMed     Text format     Abstract available


    J Racial Ethn Health Disparities

  45. LUQUE JS, Tarasenko YN, Li H, Davila CB, et al
    Utilization of Cervical Cancer Screening Among Hispanic Immigrant Women in Coastal South Carolina.
    J Racial Ethn Health Disparities. 2017 Jul 12. doi: 10.1007/s40615-017-0404.
    PubMed     Text format     Abstract available


    Jpn J Nurs Sci

  46. KIM HW, Park S, Kim Y
    Effect of community-based education to Korean mothers in relation to the prevention of cervical cancer in their daughters: A non-randomized trial.
    Jpn J Nurs Sci. 2017 Jul 13. doi: 10.1111/jjns.12179.
    PubMed     Text format     Abstract available


    Menopause

  47. MILLER TA, Flowers L
    Navigating the cervical cancer screening guidelines for women aged older than 65 years.
    Menopause. 2017 Jul 10. doi: 10.1097/GME.0000000000000913.
    PubMed     Text format     Abstract available


    Oncol Lett

  48. IMAI K, Fukuda T, Wada T, Kawanishi M, et al
    UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer.
    Oncol Lett. 2017;14:951-957.
    PubMed     Text format     Abstract available

  49. SONG R, Cong L, Ni G, Chen M, et al
    MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF.
    Oncol Lett. 2017;14:767-775.
    PubMed     Text format     Abstract available

  50. LEE SY, Lee NR, Cho DH, Kim JS, et al
    Treatment outcome analysis of chemotherapy combined with modulated electro-hyperthermia compared with chemotherapy alone for recurrent cervical cancer, following irradiation.
    Oncol Lett. 2017;14:73-78.
    PubMed     Text format     Abstract available


    Oncol Rep

  51. DONG W, Sun S, Cao X, Cui Y, et al
    Exposure to TNFalpha combined with TGFbeta induces carcinogenesis in vitro via NF-kappaB/Twist axis.
    Oncol Rep. 2017;37:1873-1882.
    PubMed     Text format     Abstract available


    Oncotarget

  52. ZHANG Y, Shi T, Yin S, Ma S, et al
    An improved nerve-sparing radical hysterectomy technique for cervical cancer using the paravesico-vaginal space as a new surgical landmark.
    Oncotarget. 2017 Jul 5. doi: 10.18632/oncotarget.19011.
    PubMed     Text format     Abstract available


    Pak J Pharm Sci

  53. SU Y, Zhang M, Zhang W, Shi H, et al
    Application research on nerve sparing radical hysterectomy for rectal function.
    Pak J Pharm Sci. 2017;30.
    PubMed     Text format     Abstract available


    PLoS One

  54. SANO H, Goto R, Hamashima C
    Does lack of resources impair access to breast and cervical cancer screening in Japan?
    PLoS One. 2017;12:e0180819.
    PubMed     Text format     Abstract available


    Sci Rep

  55. SHANKAR S, Prasad D, Sanawar R, Das AV, et al
    TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells.
    Sci Rep. 2017;7:5500.
    PubMed     Text format     Abstract available


    Tidsskr Nor Laegeforen

  56. WATHION N
    HPV vaccines are safe to use.
    Tidsskr Nor Laegeforen. 2017;137:13-14.
    PubMed     Text format    


    Tumour Biol

  57. SHU R, He J, Wu C, Gao J, et al
    The association between RARbeta and FHIT promoter methylation and the carcinogenesis of patients with cervical carcinoma: A meta-analysis.
    Tumour Biol. 2017;39:1010428317709126.
    PubMed     Text format     Abstract available

  58. ZHANG XG, Liu ZY, Liu JW, Zeng YL, et al
    Antitumor activity of a Rhodococcus sp. Lut0910 isolated from polluted soil.
    Tumour Biol. 2017;39:1010428317711661.
    PubMed     Text format     Abstract available


    Yonago Acta Med

  59. FUJII S, Iwata N, Inoue C, Mukuda N, et al
    Volume Measurement by Diffusion-Weighted Imaging in Cervical Cancer.
    Yonago Acta Med. 2017;60:113-118.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: